🔴 BreakingDrug approvalOPENFDAApr 4
FDA Approves FOUNDAYO (ORFORGLIPRON) — New Treatment Available
The FDA has approved a new drug called FOUNDAYO (orforglipron), made by Eli Lilly. This approval means the medication is now available for patients to use. The drug was officially approved on April 1, 2026.
WHY IT MATTERSWithout information about which rare disease FOUNDAYO treats, we cannot specify the patient impact — the article lacks details about the condition it addresses or which patients are eligible.
💬 Ask your doctorRead →